Real-World Outcomes and Costs Following 6 Months of Treatment with the Long-Acting Injectable (LAI) Aripiprazole Lauroxil for the Treatment of Schizophrenia

被引：0
|
作者：
John Lauriello
Peter J. Weiden
Carole D. Gleeson
Ankit Shah
Luke Boulanger
Krutika Jariwala-Parikh
Elizabeth Hedgeman
Amy K. O’Sullivan
机构：
[1] Jefferson Health—Sidney Kimmel Medical College,Department of Psychiatry and Human Behavior
[2] Thomas Jefferson University,undefined
[3] Alkermes,undefined
[4] IBM Watson Health,undefined
来源：
CNS Drugs | 2021年 / 35卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1123 / 1135
页数：12
相关论文
共 50 条
  • [31] What Is the Role of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia?
    Stroup, T. Scott
    JOURNAL OF CLINICAL PSYCHIATRY, 2014, 75 (11) : 1261 - 1262
  • [32] Duration of Pharmacotherapy with Long-Acting Injectable Risperidone in the Treatment of Schizophrenia
    Mohamed, Somaia
    Rosenheck, Robert
    Harpaz-Rotem, Ilan
    Leslie, Douglas
    Sernyak, Michael J.
    PSYCHIATRIC QUARTERLY, 2009, 80 (04) : 241 - 249
  • [33] Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia
    Park, Eun Ji
    Amatya, Sarmila
    Kim, Myung Sun
    Park, Jong Hoon
    Seol, Eunyoung
    Lee, Heeyong
    Shin, Young-Hee
    Na, Dong Hee
    ARCHIVES OF PHARMACAL RESEARCH, 2013, 36 (06) : 651 - 659
  • [34] Duration of Pharmacotherapy with Long-Acting Injectable Risperidone in the Treatment of Schizophrenia
    Somaia Mohamed
    Robert Rosenheck
    Ilan Harpaz-Rotem
    Douglas Leslie
    Michael J. Sernyak
    Psychiatric Quarterly, 2009, 80 : 241 - 249
  • [35] Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia Practical Considerations
    Kverno, Karan
    Rozenberg, Ilya
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2021, 59 (07) : 7 - 12
  • [36] Patient Outcomes Within Schizophrenia Treatment: A Look at the Role of Long-Acting Injectable Antipsychotics
    Bera, Rimal B.
    JOURNAL OF CLINICAL PSYCHIATRY, 2014, 75 : 30 - 33
  • [37] Real-World Effectiveness of Long-Acting Injectable and Oral Antipsychotic Agents in US Medicare Patients with Schizophrenia
    Li, Pengxiang
    Geng, Zhi
    Benson, Carmela
    Patel, Charmi
    Doshi, Jalpa A.
    ADVANCES IN THERAPY, 2025, 42 (02) : 1251 - 1264
  • [38] Comparison between long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia: systematic review and indirect treatment comparison
    Pae, Chi-Un
    Wang, Sheng-Min
    Han, Changsu
    Bahk, Won-Myong
    Lee, Soo-Jung
    Patkar, Ashwin A.
    Masand, Prakash S.
    Serretti, Alessandro
    Emsley, Robin
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2017, 32 (05) : 235 - 248
  • [39] Evaluating the cost and clinical effectiveness of long-acting, injectable aripiprazole and paliperidone palmitate once a month in a real-world setting
    Hodgson, Richard E.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2019, 11 : 517 - 524
  • [40] Early initiation of long-acting injectable antipsychotic treatment is associated with lower hospitalization rates and healthcare costs in patients with schizophrenia: real-world evidence from US claims data
    Munday, Jennifer
    Greene, Mallik
    Chang, Eunice
    Hartry, Ann
    Yan, Tingjian
    Broder, Michael S.
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (07) : 1231 - 1239
12345